sB7‐H1 exhibited an increasing trend in patients with clinical symptoms such as xerostomia, xerophthalmia, decayed tooth, fatigue, arthralgia, and glandular swelling, as well as in those with high IgG levels and positivity for anti‐SSB/La, anti‐SSA/Ro60, and anti‐SSA/Ro52.
← all excerpts
Identification of Plasma Biomarkers for B7 Family Members Associated With Primary Sjögren's Syndrome.
1
—
—